Jannie Ausma

Jannie Ausma has a diverse work experience in the field of clinical operations and research. Jannie is currently the Director of Clinical Operations at AbolerIS Pharma since 2023. Prior to that, they worked as the R&D Director of Clinical Development at 2 Bridge from 2018. From 2013 to 2017, they served as the Clinical Study Manager/Researcher at Danone Nutricia Research, where they managed clinical studies for infant formula to prevent and treat gastrointestinal diseases. Before that, they were the Clinical Program Director at Shire Pharmaceuticals from 2010 to 2013, managing the pediatric development plan of Resolor®. Jannie also worked as the Director of Late Development at Movetis from 2007 to 2010, focusing on the clinical development of gastrointestinal drug Resolor®. Earlier in their career, they took on roles such as Project Director at Barrier Therapeutics, Assistant Professor at Maastricht University, and Post-doctoral Fellow at the University of Maastricht.

Jannie Ausma completed their PhD in Cardiovascular Research at Maastricht University from 1992 to 1996. There is no further information available about their education history at the University of Groningen.